Buy CTI BioPharma Stock | CTIC Stock Price & Latest News | Public
CTIC

CTI BioPharma

$0.00 (0.00%)Today
    Small Market Cap

    About CTIC

    CTI BioPharma Corp. is a biopharmaceutical company, which focuses on the development, acquisition and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.07
    -0.13
    -0.2
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.15

    Actual EPS
    Q3 2020

    Stats

    Market Cap$77,4M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$1.95
    1 Year Low$0.62
    Open$1.04
    High$1.04
    Low$1.03

    Buy any stock with any amount of money.

    Download the App
    Download the app